Twist Bioscience Corp — Director's Dealing 2021

Jan 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-01-12

Reporting Person: Leproust Emily M. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-12	Common Stock	S	100	$159.47	Disposed	433096	Direct
2021-01-12	Common Stock	S	200	$161.90	Disposed	432896	Direct
2021-01-12	Common Stock	S	158	$162.9601	Disposed	432738	Direct
2021-01-12	Common Stock	S	200	$164.3750	Disposed	432538	Direct
2021-01-12	Common Stock	S	200	$165.2153	Disposed	432338	Direct
2021-01-12	Common Stock	S	100	$166.32	Disposed	432238	Direct
2021-01-12	Common Stock	S	342	$167.9351	Disposed	431896	Direct
2021-01-12	Common Stock	S	200	$169.5900	Disposed	431696	Direct
2021-01-12	Common Stock	S	200	$170.6200	Disposed	431496	Direct
2021-01-12	Common Stock	S	200	$171.9150	Disposed	431296	Direct
2021-01-12	Common Stock	S	100	$172.67	Disposed	431196	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $161.53 to $162.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $162.65 to $163.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $164.06 to $164.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $165.18 to $165.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $167.41 to $168.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $169.26 to $169.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $170.40 to $170.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F9: Represents the weighted average sales price per share. The shares sold at prices ranging from $171.53 to $172.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.